Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Interleukin-6 Overexpression Induces Pulmonary Hypertension
2008
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Neutralization of IFNγ defeats haemophagocytosis in LCMV‐infected perforin‐ and Rab27a‐deficient mice
2009
Interleukin-18 and IL-18 Binding Protein
2013
Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases
2020 StandoutNobel
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
2018
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
The Role of Natural Killer Cells in Sepsis
2011
Hepatitis B Virus-Associated Polyarteritis Nodosa
2005
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Viral infections associated with haemophagocytic syndrome
2010
Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler’s syndrome: a case report and literature review
2010
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
2012
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Interleukin-18, more than a Th1 cytokine
2013
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
2005
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial
2016
Mucosal immunity and vaccines
2005 Standout
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Epstein‐Barr Virus–Associated Hemophagocytic Lymphohistiocytosis in Adults Characterized by High Viral Genome Load within Circulating Natural Killer Cells
2010
Drug-Induced Hypersensitivity Syndrome
2009
IL-6 as a keystone cytokine in health and disease
2015 Standout
Functions of natural killer cells
2008 Standout
The cryoglobulinaemias
2011
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis
2016
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Ferritin for the clinician
2008
Treatment of Kaposi Sarcoma-Associated Herpesvirus-Associated Cancers
2012
Myocarditis
2011 Standout
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2016
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi’s sarcoma
2015 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Adult haemophagocytic syndrome
2013
Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis
2006
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
ICOS deficiency in patients with common variable immunodeficiency
2004
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
2009
COVID-19: consider cytokine storm syndromes and immunosuppression
2020 Standout
Therapeutic Approaches in Multiple Sclerosis
2002
Biomolecular coronas provide the biological identity of nanosized materials
2012 Standout
Phosphatidylserine Targets Single-Walled Carbon Nanotubes to Professional Phagocytes In Vitro and In Vivo
2009
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
2015
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities
2019
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
2004
Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis
2016
Polyarteritis nodosa: A contemporary overview
2016
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Rapid responses to anakinra in patients with refractory adult‐onset Still's disease
2005
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Inflammation in pulmonary arterial hypertension
2003
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
2002
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
2012
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
2009
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
2017 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Overview of the IL ‐1 family in innate inflammation and acquired immunity
2017
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
2014
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy
2009
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
2014
Cytokine Storm
2020 Standout
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
Familial and Acquired Hemophagocytic Lymphohistiocytosis
2011
Hemophagocytic syndromes
2007
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
ANCA-associated vasculitis as paraneoplastic syndrome with colon cancer: a case report
2005
The angiopietin-1–Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice
2009
Noninvasive monitoring of infection and rejection after lung transplantation
2015
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Overview of Castleman disease
2020
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
2009 Standout
Differentiation of Effector CD4 T Cell Populations
2010 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of C. Larroche being referenced
Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry
2011
Pathogenesis of hemophagocytic syndrome (HPS)
2003
Efficacy and safety of rituximab in common variable immunodeficiency‐associated immune cytopenias: a retrospective multicentre study on 33 patients
2011
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients
2016
Short‐term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus–related polyarteritis nodosa
2004
Castleman's disease and lymphoma: Report of eight cases in HIV‐negative patients and literature review
2002
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
2013
Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders
2002
Prevalence and Clinical Significance of Küpffer Cell Hyperplasia With Hemophagocytosis in Liver Biopsies
2011
Hodgkin Lymphoma–Associated Hemophagocytic Syndrome: A Disorder Strongly Correlated with Epstein‐Barr Virus
2008
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry
2010
Haemophagocytic syndromes in adults: current concepts and challenges ahead
2005
Successful treatment of thymoma‐associated pure red cell aplasia with intravenous immunoglobulins
2000
Epstein‐Barr Virus and Human Herpesvirus 8 Coinfection and Concomitant Extranodal Nasal‐Type NK/T Cell Lymphoma and Castleman Disease: Case Report
2003
Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome
1999
Pulmonary Hypertension in POEMS Syndrome
1998
Spontaneous Resolution of Hemophagocytic Syndrome Associated with Acute Parvovirus B19 Infection and Concomitant Epstein-Barr Virus Reactivation in an Otherwise Healthy Adult
2002
Treatment of Schnitzler's syndrome with anakinra.
2008
[Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP].
2000
[Common variable immunodeficiency: one or multiple illnesses? 3 clinical cases].
1999
Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia
2001